Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nasser Altorki

Showing results (21-30 of 98) with videos related to

Pageof 10
Sort By:
The Annals of Thoracic Surgery|January 23, 2017
Invited CommentaryNasser Altorki, Sebron W Harrison
Journal of Thoracic Disease|May 23, 2018
What is the role of wedge resection for T1a lung cancer?Sebron Harrison, Brendon Stiles, Nasser Altorki
JAMA Oncology|January 9, 2025
Uncertain Prognostic Impact of Visceral Pleural Invasion-ReplyNasser Altorki, Xiaofei Wang, Thomas E Stinchcombe
The Journal of Thoracic and Cardiovascular Surgery|March 8, 2022
Adjuvant therapy for early-stage non-small cell lung cancer: The breaking of a new dawnNasser Altorki, Jonathan Villena-Vargas, Heather Wakelee
The New England Journal of Medicine|April 26, 2023
Extent of Surgery for Stage IA Non-Small-Cell Lung Cancer. ReplyNasser Altorki, Xiaofei Wang, Thomas E Stinchcombe
JCO Oncology Practice|February 12, 2020
Lung Cancer Surveillance After Definitive Curative-Intent Therapy: ASCO Guideline SummaryBryan J Schneider, Nofisat Ismaila, Nasser Altorki
Annals of Surgery|August 10, 2002
Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagusNasser Altorki, Michael Kent, Cathy Ferrara, et al.
Statistics in Medicine|January 22, 2026
An Improved Bayesian Pick-the-Winner (IBPW) Design for Randomized Phase II Clinical TrialsWanni Lei, Maosen Peng, Nasser Altorki, et al.
Thoracic Surgery Clinics|April 23, 2015
Computed tomography screening: the international early lung cancer action program experienceClaudia I Henschke, Paolo Boffetta, David F Yankelevitz, et al.
Translational Lung Cancer Research|May 19, 2020
Anti-PDL1 effect in squamous non-small cell lung cancerMohamed Rahouma, Massimo Baudo, Mohamed Kamel, et al.
Pageof 10

Showing results (21-30 of 98) with videos related to

Sort By:
Pageof 10
The Annals of Thoracic Surgery|January 23, 2017
Invited CommentaryNasser Altorki, Sebron W Harrison
Journal of Thoracic Disease|May 23, 2018
What is the role of wedge resection for T1a lung cancer?Sebron Harrison, Brendon Stiles, Nasser Altorki
JAMA Oncology|January 9, 2025
Uncertain Prognostic Impact of Visceral Pleural Invasion-ReplyNasser Altorki, Xiaofei Wang, Thomas E Stinchcombe
The Journal of Thoracic and Cardiovascular Surgery|March 8, 2022
Adjuvant therapy for early-stage non-small cell lung cancer: The breaking of a new dawnNasser Altorki, Jonathan Villena-Vargas, Heather Wakelee
The New England Journal of Medicine|April 26, 2023
Extent of Surgery for Stage IA Non-Small-Cell Lung Cancer. ReplyNasser Altorki, Xiaofei Wang, Thomas E Stinchcombe
JCO Oncology Practice|February 12, 2020
Lung Cancer Surveillance After Definitive Curative-Intent Therapy: ASCO Guideline SummaryBryan J Schneider, Nofisat Ismaila, Nasser Altorki
Annals of Surgery|August 10, 2002
Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagusNasser Altorki, Michael Kent, Cathy Ferrara, et al.
Statistics in Medicine|January 22, 2026
An Improved Bayesian Pick-the-Winner (IBPW) Design for Randomized Phase II Clinical TrialsWanni Lei, Maosen Peng, Nasser Altorki, et al.
Thoracic Surgery Clinics|April 23, 2015
Computed tomography screening: the international early lung cancer action program experienceClaudia I Henschke, Paolo Boffetta, David F Yankelevitz, et al.
Translational Lung Cancer Research|May 19, 2020
Anti-PDL1 effect in squamous non-small cell lung cancerMohamed Rahouma, Massimo Baudo, Mohamed Kamel, et al.
Pageof 10